Pulmonary Hypoplasia Induced by Oligohydramnios: Findings from Animal Models and a Population-Based Study

Chun-Shan Wu1, Chung-Ming Chen2, Hsiu-Chu Chou3

  • 1Department of Pediatrics, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan.

Insights

Oligohydramnios, a condition of low amniotic fluid, severely impacts fetal lung development, leading to pulmonary hypoplasia. This review explores its effects on lung structure and long-term respiratory health in newborns.

Area of Science:

  • Neonatal Medicine
  • Developmental Biology
  • Respiratory Physiology

Background:

  • Pulmonary hypoplasia is a major cause of neonatal mortality.
  • Oligohydramnios is frequently associated with pulmonary hypoplasia.
  • Fetal lung growth depends on physical forces like lung liquid and breathing movements.

Purpose of the Study:

  • To review the impact of oligohydramnios on fetal lung development.
  • To discuss mechanisms of oligohydramnios-induced pulmonary hypoplasia from animal studies.
  • To describe long-term respiratory outcomes in children exposed to oligohydramnios in utero.

Main Methods:

  • Literature review of studies on oligohydramnios and lung development.
  • Analysis of animal models investigating the mechanisms of pulmonary hypoplasia.
  • Examination of population-based data on long-term respiratory outcomes.

Main Results:

  • Oligohydramnios restricts intrathoracic space, impairing fetal lung growth.
  • Animal studies reveal various mechanisms linking oligohydramnios to structural respiratory changes.
  • Population data indicates potential long-term respiratory consequences for exposed children.

Conclusions:

  • Oligohydramnios significantly disrupts normal fetal lung development.
  • Understanding the mechanisms is crucial for potential interventions.
  • Further research is needed on the long-term respiratory health of affected children.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
790
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.4K
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.6K
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
66.2K